Diclofenac May Boost MI Risk in Patients With Spondyloarthritis Diclofenac May Boost MI Risk in Patients With Spondyloarthritis
Risk of myocardial infarction (MI) is increased in patients with spondyloarthritis (SpA) who use the nonsteroidal anti-inflammatory drug (NSAID) diclofenac but not in those who take naproxen, researchers say.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 7, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news
Better GI Safety With Celecoxib Plus Esomeprazole for Arthritis Pain Better GI Safety With Celecoxib Plus Esomeprazole for Arthritis Pain
Celecoxib has a better gastrointestinal safety profile in arthritis patients than ibuprofen or naproxen when all drugs are co-prescribed with esomeprazole, according to data from the PRECISION trial.Reuters Health Information (Source: Medscape Orthopaedics Headlines)
Source: Medscape Orthopaedics Headlines - May 3, 2018 Category: Orthopaedics Tags: Rheumatology News Source Type: news
New research ranks the effectiveness of nonsurgical treatments for knee osteoarthritis
(American Academy of Orthopaedic Surgeons) An estimated 45 percent of people are at risk of developing knee osteoarthritis (OA) in their lifetime. According to a network meta-analysis research article published in the May 1, 2018 issue of the Journal of the American Academy of Orthopaedic Surgeons (JAAOS), the nonsteroidal anti-inflammatory drug (NSAID) naproxen was ranked most effective in individual knee OA treatment for improving both pain and function, and is considered a relatively safe and low-cost treatment method. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 1, 2018 Category: International Medicine & Public Health Source Type: news
FDA Panels Vote to Add Aspirin Warning to Naproxen Label FDA Panels Vote to Add Aspirin Warning to Naproxen Label
Two FDA panels voted to include a warning against concomitant aspirin use on the naproxen nonprescription Drug Facts label, and to make no such changes to the current ibuprofen label.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 26, 2018 Category: Consumer Health News Tags: Rheumatology News Source Type: news
CV Safety of Celecoxib Similar to Naproxen, Ibuprofen: FDA Panels Say CV Safety of Celecoxib Similar to Naproxen, Ibuprofen: FDA Panels Say
Two FDA panels jointly voted by a large margin that the cardiovascular safety of celecoxib is comparable to naproxen and ibuprofen.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 25, 2018 Category: Consumer Health News Tags: Rheumatology News Source Type: news
CV Safety of Celecoxib Similar to Naproxen, Ibuprofen, FDA Panels Say CV Safety of Celecoxib Similar to Naproxen, Ibuprofen, FDA Panels Say
Two FDA panels jointly voted by a large margin that the cardiovascular safety of celecoxib is comparable to naproxen and ibuprofen.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 25, 2018 Category: Consumer Health News Tags: Rheumatology News Source Type: news
FDA Panel Gives Celecoxib Positive CV Safety Grade
(MedPage Today) -- Votes 15-5 that it is non-inferior to naproxen, ibuprofen (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - April 25, 2018 Category: Cardiology Source Type: news
Diclofenac Raises MI Risk in Spondyloarthritis (CME/CE)
(MedPage Today) -- No special risk seen for naproxen (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - April 25, 2018 Category: Cardiology Source Type: news
What to D.O.: When Ibuprofen Fails, Naproxen Isn't the Answer
No abstract available (Source: Emergency Medicine News)
Source: Emergency Medicine News - April 1, 2018 Category: Emergency Medicine Tags: What to D.O Source Type: news
Prescription pain relievers raise risk of irregular heartbeat, study shows
Cardiologist Dr. Tara Narula breaks down the study of prescription-strength NSAIDs like ibuprofen and naproxen (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - March 21, 2018 Category: Consumer Health News Source Type: news
Aleve (naproxen) vs. Celebrex (celecoxib)
Title: Aleve (naproxen) vs. Celebrex (celecoxib)Category: MedicationsCreated: 2/16/2018 12:00:00 AMLast Editorial Review: 2/16/2018 12:00:00 AM (Source: MedicineNet Chronic Pain General)
Source: MedicineNet Chronic Pain General - February 16, 2018 Category: Anesthesiology Source Type: news
Nearly one out of five NSAID users exceed daily limit
(Boston University School of Medicine) Chances are you or someone you know has used nonsteroidal anti-inflammatory drugs (NSAIDs) within the last month. NSAIDs, such as Advil (ibuprofen), Aleve (naproxen) and Celebrex, are among the most commonly used medicines in the US. Now, for the first time, researchers have found that 15 percent of adult ibuprofen users exceed the maximum recommended dose of ibuprofen or other NSAIDs in a one-week period. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 26, 2018 Category: International Medicine & Public Health Source Type: news
Magno-Humphries Laboratories, Inc., Issues Voluntary Nationwide Recall of Basic Drugs Brand of Senna Laxative Due to Mislabeling
Tigard, OR, Magno-Humphries Laboratories, Inc., is voluntarily recalling one lot of Basic Drugs Brand of Senna Laxative tablets, 8.6mg Sennosides to the consumer level due to a customer complaint that their bottle labeled as Senna Laxative actually contained Basic Drugs Brand of Naproxen Sodium 220mg. Naproxen Sodium 220mg tablet is used as a pain reliever and is a nonsteroidal anti-inflammatory drug (NSAID). (Source: Food and Drug Administration)
Source: Food and Drug Administration - January 22, 2018 Category: Food Science Source Type: news
PRECISION: Aspirin Undermines Safety Profile of Celecoxib PRECISION: Aspirin Undermines Safety Profile of Celecoxib
Further analysis from PRECISION shows that although celecoxib may be safer than naproxen or ibuprofen, adding aspirin may undermine that safety advantage.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 4, 2017 Category: Consumer Health News Tags: Cardiology News Source Type: news
FDA Drug Safety Communication: FDA strengthens warning that non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) can cause heart attacks or strokes
[FDA strengthens warning that non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) can cause heart attacks or strokes (FDA Drug Safety Communication). Based on FDA ’s comprehensive review of new safety information, the agency is requiring updates to the drug labels of all prescription NSAIDs. Widely used to treat pain and fever from many different long- and short-term medical conditions such as arthritis, menstrual cramps, headaches, colds, and the flu, NSAI Ds are available by prescription and OTC. Examples of NSAIDs include ibuprofen, naproxen, diclofenac, and celecoxib. (Source: FDA Center for Drug Evaluation and...
Source: FDA Center for Drug Evaluation and Research - What's New - November 16, 2017 Category: Drugs & Pharmacology Source Type: news
